Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02639182
Title A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Agensys, Inc.
Indications

renal cell carcinoma

Therapies

AGS16F

Axitinib

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.